Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety.
Cohen, F., Aggen, J.B., Andrews, L.D., Assar, Z., Boggs, J., Choi, T., Dozzo, P., Easterday, A.N., Haglund, C.M., Hildebrandt, D.J., Holt, M.C., Joly, K., Jubb, A., Kamal, Z., Kane, T.R., Konradi, A.W., Krause, K.M., Linsell, M.S., Machajewski, T.D., Miroshnikova, O., Moser, H.E., Nieto, V., Phan, T., Plato, C., Serio, A.W., Seroogy, J., Shakhmin, A., Stein, A.J., Sun, A.D., Sviridov, S., Wang, Z., Wlasichuk, K., Yang, W., Zhou, X., Zhu, H., Cirz, R.T.
Chemmedchem
